Analysts upgrade share price targets for Bavarian after run of good news
The Bavarian Nordic share price continues to rise on Thursday on account of new targets that predict a big upside for the stock.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
After the Danish government announced plans to support Bavarian Nordic’s vaccine candidate with DKK 800m (USD 128m) in financial aid in mid-August, the company's share price has gone up by 33 percent. The company has therefore cemented its place as the C25 index's winning stock this year with returns of about 85 percent, writes Danish business daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pfizer begins phase III trial for vaccine against RSV
For subscribers
